Funding to support commercialization of ExoView™ system BOSTON–NanoView Biosciences, an emerging leader in the field of exosome detection and characterization, today announced the closing of a $10 million Series B financing led by Northpond Ventures. Existing investors, including Sands Capital Ventures and PBM Capital Group, participated in the financing round. Proceeds will be used to […]

Label individual cells with uniquely identifiable, expressed barcodes to understand how different experimental conditions affect distinct groups of cells from a common progenitor MOUNTAIN VIEW, Calif. — Cellecta, Inc. today introduced the CloneTracker XP™ Expressed Lentiviral Barcode Library and CloneTracker XP™ Barcoded CRISPR Library product lines. The ability to label and trace individual cells is a powerful experimental […]

SAN DIEGO – Maravai LifeSciences, a leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, today announced that it has hired Christopher Shaffer as senior director of oligonucleotide process development for TriLink BioTechnologies. In this new position, Shaffer will develop and refine processes that improve overall efficiency and will be instrumental when TriLink […]

Cambridge, UK – Abcam’s new phosphate buffered saline (PBS)-only recombinant antibodies are free from preservatives and stabilising agents, offering improved flexibility for researchers conducting more complex experiments. Typically, antibodies are stored in a buffer composed of bovine serum albumin (BSA), glycerol and sodium azide to ensure stability. However, these components can inhibit effective conjugation to certain […]

WAKEFIELD, Mass.–Genetics Research LLC, an inventor of innovative technologies for the development of products for genomic analysis in research, diagnostics, and therapeutics, announced today that the U.S. Patent and Trademark Office granted the Company U.S. Patent No. 10,081,829, entitled “Detection of targeted sequence regions.” The patent covers a novel method for enriching sequence specific nucleic […]

Menlo Park, CA – Personalis, Inc., a provider of advanced genomic sequencing and analytics for immuno-oncology, today announced an extension to their contract with the US Department of Veterans Affairs (VA) to sequence a further 34,000 whole human genomes for the VA’s Million Veteran Program (MVP).  This brings the total of all Personalis contracts from […]

FUJISAWA CITY, Japan & DUBLIN–GenAhead Bio Incorporated (“GenAhead”) and ERS Genomics Limited (“ERS Genomics”) announced today a non-exclusive license agreement to provide GenAhead with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents. ERS Genomics holds rights to the foundational CRISPR/Cas9 patent portfolio from Dr. Emmanuelle Charpentier, co-inventor of the breakthrough gene editing technology. GenAhead had its start […]

Chromatrap® has introduced a new and improved version of it’s popular solid phase chromatin immunoprecipitation (ChIP) assay kit for chromatin extracted from Formalin Fixed Paraffin Embedded (FFPE) tissue. Ideal for tissue samples, biopsies and difficult to lyse samples, the Chromatrap® FFPE ChIP-seq kit has overcome the issues often associated with FFPE ChIP, by offering a streamlined protocol which […]

Madrid and London – Aglaris Ltd. today announced the appointment of Steven Docksey to the role of CEO of the Anglo-Spanish cell therapy equipment manufacturer, effective immediately. Aglaris is creating transformative technologies to address the key challenges associated with the consistency, scalability and flexibility of manufacturing for allogeneic and autologous cell-based therapies (CBT).  The Company has […]

Diploid Assembly of a Puerto Rican Female Adds a Rich Resource to Population-Specific Reference Genomes MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced it has produced the most contiguous diploid human genome assembly of a single individual to date, representing the nearly […]